Emergent BioSolutions

Emergent BioSolutions is a global life sciences company dedicated to developing, manufacturing, and delivering solutions that protect and enhance lives.

Founded in 1998 and headquartered in Gaithersburg, Maryland, Emergent BioSolutions focuses on addressing critical public health threats through the innovation and supply of vaccines, therapeutics, and drug-device combination products. The company partners with government agencies, healthcare providers, and organisations worldwide to combat challenges such as infectious diseases, opioid overdoses, and chemical, biological, radiological, and nuclear (CBRN) threats. Emergent also provides contract development and manufacturing organisation (CDMO) services, leveraging its state-of-the-art facilities and expertise.

Key Products and Services:

• Vaccines and Therapeutics: Including anthrax and smallpox vaccines.
• Overdose Reversal Products: NARCAN® Nasal Spray and KLOXXADO® Nasal Spray.
• CBRN Countermeasures: Treatments and devices for biodefence preparedness.
• CDMO Services: Customised solutions for drug development and manufacturing.

Emergent BioSolutions remains committed to its mission of protecting and enhancing lives. Through its robust portfolio and strategic partnerships, the company addresses some of the most pressing global health challenges while fostering innovation to ensure a safer, healthier future.